| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.705 | 0.008 | 0.705 | Aldehyde oxidase inhibitor | 0.698 0.008 CID_169703 | ||
| 0.626 | 0.003 | 0.626 | Nav1.1 sodium channel blocker | 0.606 0.003 CID_169703 | ||
| 0.598 | 0.036 | 0.625 | Caspase 9 stimulant | 0.625 0.033 CID_169703 | CID_169703 | |
| 0.546 | 0.005 | 0.546 | Anesthetic general | 0.537 0.006 CID_169703 | ||
| 0.521 | 0.003 | 0.527 | Aldose reductase inhibitor | 0.527 0.003 CID_169703 | CID_169703 | |
| 0.513 | 0.011 | 0.513 | Anticonvulsant | 0.495 0.012 CID_169703 | ||
| 0.483 | 0.031 | 0.483 | GABA C receptor rho-3 antagonist | 0.424 0.051 CID_169703 | ||
| 0.46 | 0.013 | 0.462 | Peroxidase inhibitor | 0.462 0.013 CID_169703 | CID_169703 | |
| 0.443 | 0.005 | 0.448 | Tumour necrosis factor antagonist | 0.448 0.005 CID_169703 | CID_169703 | |
| 0.378 | 0.004 | 0.378 | Alcohol dehydrogenase inhibitor | 0.339 0.005 CID_169703 | ||
| 0.393 | 0.041 | 0.412 | Spasmolytic | 0.412 0.038 CID_169703 | CID_169703 | |
| 0.354 | 0.023 | 0.379 | RNA-directed DNA polymerase inhibitor | 0.379 0.02 CID_169703 | CID_169703 | |
| 0.358 | 0.035 | 0.393 | Superoxide dismutase inhibitor | 0.393 0.028 CID_169703 | CID_169703 | |
| 0.333 | 0.02 | 0.333 | Tyrosine 3 hydroxylase inhibitor | 0.333 0.02 CID_169703 | ||
| 0.388 | 0.089 | 0.388 | Calcium channel L-type activator | 0.301 0.157 CID_169703 | ||
| 0.377 | 0.087 | 0.396 | Histamine release inhibitor | 0.396 0.078 CID_169703 | CID_169703 | |
| 0.373 | 0.107 | 0.398 | Cyclophilin D inhibitor | 0.398 0.092 CID_169703 | CID_169703 | |
| 0.334 | 0.069 | 0.334 | Immunostimulant | 0.325 0.072 CID_169703 | ||
| 0.382 | 0.123 | 0.433 | DNA directed DNA polymerase inhibitor | 0.433 0.103 CID_169703 | CID_169703 | |
| 0.293 | 0.045 | 0.31 | Cyclic AMP phosphodiesterase inhibitor | 0.31 0.038 CID_169703 | CID_169703 | |
| 0.259 | 0.014 | 0.261 | Cystathionine beta-synthase inhibitor | 0.261 0.014 CID_169703 | CID_169703 | |
| 0.273 | 0.036 | 0.28 | Peptidyltransferase inhibitor | 0.28 0.033 CID_169703 | CID_169703 | |
| 0.243 | 0.014 | 0.243 | UDP-glucose 4-epimerase inhibitor | 0.243 0.014 CID_169703 | ||
| 0.279 | 0.051 | 0.279 | DNA synthesis inhibitor | 0.257 0.062 CID_169703 | ||
| 0.265 | 0.04 | 0.265 | Growth hormone agonist | 0.237 0.047 CID_169703 | ||
| 0.338 | 0.126 | 0.338 | 5 Hydroxytryptamine release inhibitor | 0.296 0.169 CID_169703 | ||
| 0.244 | 0.037 | 0.249 | Nitric-oxide synthase stimulant | 0.249 0.033 CID_169703 | CID_169703 | |
| 0.282 | 0.076 | 0.282 | 5 Hydroxytryptamine release stimulant | 0.221 0.105 CID_169703 | ||
| 0.21 | 0.009 | 0.21 | Creatine kinase inhibitor | 0.209 0.009 CID_169703 | ||
| 0.262 | 0.063 | 0.291 | Vasodilator | 0.291 0.051 CID_169703 | CID_169703 | |
| 0.207 | 0.009 | 0.207 | Phosphodiesterase 7B inhibitor | 0.207 0.009 CID_169703 | ||
| 0.216 | 0.029 | 0.295 | M18 aspartyl aminopeptidase inhibitor | 0.295 0.013 CID_169703 | CID_169703 | |
| 0.241 | 0.065 | 0.241 | Neuropeptide Y2 antagonist | 0.212 0.1 CID_169703 | ||
| 0.327 | 0.151 | 0.374 | DNA polymerase beta inhibitor | 0.374 0.129 CID_169703 | CID_169703 | |
| 0.199 | 0.035 | 0.199 | Neurotensin receptor agonist | 0.177 0.053 CID_169703 | ||
| 0.194 | 0.032 | 0.194 | GABA C receptor rho-2 antagonist | 0.169 0.051 CID_169703 | ||
| 0.17 | 0.011 | 0.17 | Keratolytic | 0.168 0.012 CID_169703 | ||
| 0.244 | 0.087 | 0.283 | 5 Hydroxytryptamine uptake stimulant | 0.283 0.055 CID_169703 | CID_169703 | |
| 0.183 | 0.027 | 0.183 | Nav1.6 sodium channel blocker | 0.168 0.037 CID_169703 | ||
| 0.215 | 0.061 | 0.216 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.216 0.06 CID_169703 | CID_169703 | |
| 0.324 | 0.182 | 0.324 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.324 0.182 CID_169703 | ||
| 0.146 | 0.005 | 0.148 | Phosphodiesterase VII inhibitor | 0.148 0.004 CID_169703 | CID_169703 | |
| 0.153 | 0.02 | 0.156 | DOPA decarboxylase inhibitor | 0.156 0.018 CID_169703 | CID_169703 | |
| 0.229 | 0.097 | 0.253 | Cardiotonic | 0.253 0.08 CID_169703 | CID_169703 | |
| 0.15 | 0.018 | 0.15 | NADH dehydrogenase inhibitor | 0.15 0.018 CID_169703 | ||
| 0.141 | 0.011 | 0.141 | Phosphodiesterase III inhibitor | 0.138 0.012 CID_169703 | ||
| 0.238 | 0.108 | 0.239 | Insulysin inhibitor | 0.239 0.107 CID_169703 | CID_169703 | |
| 0.213 | 0.087 | 0.289 | Free radical scavenger | 0.289 0.055 CID_169703 | CID_169703 | |
| 0.186 | 0.062 | 0.205 | Succinate dehydrogenase inhibitor | 0.205 0.045 CID_169703 | CID_169703 | |
| 0.15 | 0.027 | 0.15 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.15 0.027 CID_169703 | ||
| 0.152 | 0.03 | 0.154 | DNA repair enzyme inhibitor | 0.154 0.028 CID_169703 | CID_169703 | |
| 0.145 | 0.027 | 0.184 | HIV-1 integrase (Overall Integration) inhibitor | 0.184 0.015 CID_169703 | CID_169703 | |
| 0.126 | 0.008 | 0.126 | Cathepsin E inhibitor | 0.123 0.008 CID_169703 | ||
| 0.164 | 0.049 | 0.164 | Nav1.2 sodium channel blocker | 0.139 0.064 CID_169703 | ||
| 0.196 | 0.081 | 0.203 | Neurotrophic factor enhancer | 0.203 0.074 CID_169703 | CID_169703 | |
| 0.213 | 0.101 | 0.221 | Hypoglycemic | 0.221 0.095 CID_169703 | CID_169703 | |
| 0.281 | 0.169 | 0.307 | Alpha-glucosidase inhibitor | 0.307 0.156 CID_169703 | CID_169703 | |
| 0.122 | 0.014 | 0.122 | Alcohol oxidase inhibitor | 0.084 0.023 CID_169703 | ||
| 0.145 | 0.036 | 0.15 | Xanthine oxidase inhibitor | 0.15 0.034 CID_169703 | CID_169703 | |
| 0.158 | 0.05 | 0.166 | Adenylate cyclase stimulant | 0.166 0.039 CID_169703 | CID_169703 | |
| 0.13 | 0.023 | 0.13 | Histidine decarboxylase inhibitor | 0.126 0.024 CID_169703 | ||
| 0.144 | 0.039 | 0.144 | 5 Hydroxytryptamine 3A agonist | 0.113 0.062 CID_169703 | ||
| 0.142 | 0.037 | 0.142 | GABA C receptor agonist | 0.142 0.037 CID_169703 | ||
| 0.108 | 0.004 | 0.11 | Phosphodiesterase 7A inhibitor | 0.11 0.004 CID_169703 | CID_169703 | |
| 0.21 | 0.108 | 0.224 | DNA damaging | 0.224 0.097 CID_169703 | CID_169703 | |
| 0.267 | 0.168 | 0.267 | Analgesic | |||
| 0.117 | 0.019 | 0.132 | Phenylalanine 4-hydroxylase inhibitor | 0.132 0.015 CID_169703 | CID_169703 | |
| 0.121 | 0.024 | 0.126 | Metalloproteinase-9 inhibitor | 0.126 0.023 CID_169703 | CID_169703 | |
| 0.124 | 0.028 | 0.127 | Metalloproteinase-2 inhibitor | 0.127 0.026 CID_169703 | CID_169703 | |
| 0.128 | 0.033 | 0.128 | Anabolic | 0.118 0.041 CID_169703 | ||
| 0.15 | 0.055 | 0.15 | Alpha-N-acetylglucosaminidase inhibitor | 0.15 0.055 CID_169703 | ||
| 0.102 | 0.013 | 0.102 | Phospholipase D inhibitor | 0.097 0.017 CID_169703 | ||
| 0.199 | 0.114 | 0.255 | Antioxidant | 0.255 0.081 CID_169703 | CID_169703 | |
| 0.107 | 0.022 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.109 0.02 CID_169703 | CID_169703 | |
| 0.088 | 0.004 | 0.088 | Calcitonin gene-related peptide 1 receptor antagonist | 0.077 0.004 CID_169703 | ||
| 0.149 | 0.065 | 0.185 | Mannose-6-phosphate isomerase inhibitor | 0.185 0.039 CID_169703 | CID_169703 | |
| 0.112 | 0.03 | 0.112 | Interleukin 5 antagonist | 0.096 0.046 CID_169703 | ||
| 0.101 | 0.021 | 0.101 | CC chemokine 5 receptor agonist | 0.089 0.039 CID_169703 | ||
| 0.095 | 0.018 | 0.095 | NMDA 2C receptor antagonist | 0.073 0.03 CID_169703 | ||
| 0.085 | 0.008 | 0.092 | Dihydroorotate oxidase inhibitor | 0.092 0.006 CID_169703 | CID_169703 | |
| 0.117 | 0.041 | 0.117 | Prolactin inhibitor | 0.111 0.045 CID_169703 | ||
| 0.115 | 0.039 | 0.115 | Estrogen receptor beta antagonist | |||
| 0.109 | 0.035 | 0.109 | Phosphodiesterase I inhibitor | 0.107 0.037 CID_169703 | ||
| 0.15 | 0.077 | 0.15 | CF transmembrane conductance regulator agonist | 0.128 0.122 CID_169703 | ||
| 0.141 | 0.068 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.068 CID_169703 | ||
| 0.076 | 0.004 | 0.076 | Calcitonin gene-related peptide antagonist | 0.074 0.004 CID_169703 | ||
| 0.101 | 0.029 | 0.104 | Glutamate decarboxylase inhibitor | 0.104 0.027 CID_169703 | CID_169703 | |
| 0.122 | 0.051 | 0.122 | Estrogen antagonist | |||
| 0.132 | 0.062 | 0.132 | Nav1.3 sodium channel blocker | 0.117 0.077 CID_169703 | ||
| 0.098 | 0.028 | 0.098 | Estrogen-related receptor beta agonist | 0.088 0.046 CID_169703 | ||
| 0.076 | 0.007 | 0.079 | Dopamine D5 agonist | 0.079 0.006 CID_169703 | CID_169703 | |
| 0.153 | 0.085 | 0.165 | Arachidonic acid antagonist | 0.165 0.071 CID_169703 | CID_169703 | |
| 0.086 | 0.02 | 0.089 | Carbonic anhydrase VB inhibitor | 0.089 0.019 CID_169703 | CID_169703 | |
| 0.108 | 0.042 | 0.108 | NMDA receptor antagonist | 0.082 0.063 CID_169703 | ||
| 0.087 | 0.023 | 0.087 | Biliverdin reductase inhibitor | 0.087 0.023 CID_169703 | ||
| 0.125 | 0.063 | 0.143 | Adenylate cyclase inhibitor | 0.143 0.05 CID_169703 | CID_169703 | |
| 0.081 | 0.019 | 0.081 | NMDA 2A receptor antagonist | 0.057 0.031 CID_169703 | ||
| 0.111 | 0.049 | 0.111 | GABA C receptor rho-1 antagonist | 0.095 0.069 CID_169703 | ||
| 0.214 | 0.152 | 0.216 | Cholesterol antagonist | 0.216 0.151 CID_169703 | CID_169703 | |
| 0.084 | 0.023 | 0.084 | Glutamate (mGluR7) antagonist | 0.077 0.032 CID_169703 | ||
| 0.099 | 0.038 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.092 0.042 CID_169703 | ||
| 0.095 | 0.034 | 0.095 | Analgesic, opioid | 0.071 0.059 CID_169703 | ||
| 0.088 | 0.027 | 0.088 | Secretase beta inhibitor | 0.087 0.028 CID_169703 | ||
| 0.069 | 0.009 | 0.069 | Nicotinic acid receptor agonist | 0.045 0.017 CID_169703 | ||
| 0.099 | 0.04 | 0.102 | Carbonic anhydrase VI inhibitor | 0.102 0.038 CID_169703 | CID_169703 | |
| 0.088 | 0.029 | 0.088 | MAP kinase kinase 7 inhibitor | 0.078 0.052 CID_169703 | ||
| 0.089 | 0.031 | 0.09 | Carbonic anhydrase VA inhibitor | 0.09 0.03 CID_169703 | CID_169703 | |
| 0.175 | 0.117 | 0.221 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.221 0.089 CID_169703 | CID_169703 | |
| 0.072 | 0.015 | 0.072 | Ryanodine receptor antagonist | 0.072 0.015 CID_169703 | ||
| 0.083 | 0.026 | 0.083 | NMDA receptor glycine site agonist | 0.083 0.026 CID_169703 | ||
| 0.061 | 0.005 | 0.062 | Protein kinase (CK2) beta inhibitor | 0.062 0.005 CID_169703 | CID_169703 | |
| 0.122 | 0.066 | 0.122 | Alkylator | 0.117 0.071 CID_169703 | ||
| 0.059 | 0.005 | 0.059 | Uridine phosphorylase inhibitor | 0.059 0.005 CID_169703 | ||
| 0.076 | 0.022 | 0.078 | Phosphodiesterase 1C inhibitor | 0.078 0.021 CID_169703 | CID_169703 | |
| 0.089 | 0.036 | 0.089 | Phosphofructokinase-1 inhibitor | 0.089 0.036 CID_169703 | ||
| 0.109 | 0.057 | 0.11 | Beta glucuronidase inhibitor | 0.11 0.056 CID_169703 | CID_169703 | |
| 0.084 | 0.033 | 0.087 | Carbonic anhydrase V inhibitor | 0.087 0.032 CID_169703 | CID_169703 | |
| 0.074 | 0.023 | 0.074 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.074 0.023 CID_169703 | ||
| 0.077 | 0.026 | 0.077 | Collagenase 3 inhibitor | 0.075 0.028 CID_169703 | ||
| 0.216 | 0.166 | 0.216 | Sodium/bile acid cotransporter inhibitor | |||
| 0.111 | 0.062 | 0.111 | GABA C receptor antagonist | 0.098 0.082 CID_169703 | ||
| 0.114 | 0.066 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.066 CID_169703 | ||
| 0.08 | 0.032 | 0.086 | Neutrophil collagenase inhibitor | 0.086 0.028 CID_169703 | CID_169703 | |
| 0.226 | 0.177 | 0.226 | Calcium channel activator | |||
| 0.083 | 0.035 | 0.085 | Matrix metalloproteinase inhibitor | 0.085 0.034 CID_169703 | CID_169703 | |
| 0.137 | 0.089 | 0.139 | Heat shock protein 70 antagonist | 0.139 0.079 CID_169703 | CID_169703 | |
| 0.075 | 0.027 | 0.075 | Androgen agonist | 0.064 0.036 CID_169703 | ||
| 0.105 | 0.058 | 0.105 | Bronchodilator | 0.104 0.059 CID_169703 | ||
| 0.088 | 0.042 | 0.088 | Porphobilinogen synthase inhibitor | 0.088 0.042 CID_169703 | ||
| 0.206 | 0.161 | 0.226 | Caspase 3 stimulant | 0.226 0.136 CID_169703 | CID_169703 | |
| 0.148 | 0.104 | 0.154 | ATPase inhibitor | 0.154 0.095 CID_169703 | CID_169703 | |
| 0.14 | 0.097 | 0.14 | Melanin inhibitor | 0.139 0.097 CID_169703 | ||
| 0.074 | 0.032 | 0.074 | Carbamoyl phosphate synthetase inhibitor | 0.074 0.032 CID_169703 | ||
| 0.071 | 0.03 | 0.071 | Phosphodiesterase 1B inhibitor | 0.068 0.033 CID_169703 | ||
| 0.09 | 0.051 | 0.104 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.03 CID_169703 | CID_169703 | |
| 0.098 | 0.059 | 0.104 | DNA directed RNA polymerase inhibitor | 0.104 0.052 CID_169703 | CID_169703 | |
| 0.092 | 0.053 | 0.092 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 CID_169703 | ||
| 0.085 | 0.046 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.088 0.044 CID_169703 | CID_169703 | |
| 0.195 | 0.158 | 0.211 | 12-Lipoxygenase inhibitor | 0.211 0.139 CID_169703 | CID_169703 | |
| 0.132 | 0.095 | 0.139 | NOS3 expression enhancer | 0.139 0.085 CID_169703 | CID_169703 | |
| 0.066 | 0.03 | 0.066 | Phosphodiesterase 1A inhibitor | 0.065 0.031 CID_169703 | ||
| 0.071 | 0.035 | 0.071 | NMDA receptor agonist | 0.066 0.039 CID_169703 | ||
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | 0.036 0.007 CID_169703 | ||
| 0.105 | 0.07 | 0.115 | Mucolytic | 0.115 0.059 CID_169703 | CID_169703 | |
| 0.117 | 0.083 | 0.12 | Amylase inhibitor | 0.12 0.081 CID_169703 | CID_169703 | |
| 0.103 | 0.068 | 0.103 | Ferrochelatase inhibitor | 0.103 0.068 CID_169703 | ||
| 0.09 | 0.056 | 0.09 | Opioid antagonist | |||
| 0.074 | 0.043 | 0.074 | Opioid mu receptor antagonist | |||
| 0.046 | 0.016 | 0.046 | Nicotinic acid receptor 2 agonist | 0.037 0.024 CID_169703 | ||
| 0.122 | 0.091 | 0.154 | Lipid peroxidase inhibitor | 0.154 0.066 CID_169703 | CID_169703 | |
| 0.038 | 0.007 | 0.038 | Thyroid hormone agonist | 0.036 0.008 CID_169703 | ||
| 0.064 | 0.034 | 0.064 | Argininosuccinate synthase inhibitor | 0.064 0.034 CID_169703 | ||
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | 0.047 0.017 CID_169703 | ||
| 0.049 | 0.02 | 0.049 | Thymidine kinase inhibitor | 0.048 0.02 CID_169703 | ||
| 0.075 | 0.047 | 0.075 | NMDA 2 receptor antagonist | |||
| 0.089 | 0.061 | 0.089 | Triose-phosphate isomerase inhibitor | 0.089 0.061 CID_169703 | ||
| 0.082 | 0.055 | 0.082 | Adrenaline agonist | 0.081 0.057 CID_169703 | ||
| 0.075 | 0.049 | 0.078 | Lipase inhibitor | 0.078 0.045 CID_169703 | CID_169703 | |
| 0.13 | 0.104 | 0.13 | Hexokinase inhibitor | |||
| 0.144 | 0.118 | 0.144 | Phospholipase C inhibitor | 0.143 0.12 CID_169703 | ||
| 0.142 | 0.117 | 0.142 | Lipocortins synthesis antagonist | 0.142 0.117 CID_169703 | ||
| 0.129 | 0.104 | 0.131 | Cyclin-dependent kinase 8 inhibitor | 0.131 0.101 CID_169703 | CID_169703 | |
| 0.126 | 0.102 | 0.136 | Insulin secretagoues | 0.136 0.09 CID_169703 | CID_169703 | |
| 0.105 | 0.082 | 0.105 | Topoisomerase II inhibitor | 0.1 0.086 CID_169703 | ||
| 0.116 | 0.093 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 CID_169703 | ||
| 0.052 | 0.031 | 0.052 | Bombesin 2 receptor antagonist | 0.047 0.039 CID_169703 | ||
| 0.031 | 0.01 | 0.033 | Thymidine phosphorylase inhibitor | 0.033 0.009 CID_169703 | CID_169703 | |
| 0.092 | 0.071 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.06 CID_169703 | CID_169703 | |
| 0.071 | 0.05 | 0.073 | Alpha 1a adrenoreceptor antagonist | 0.073 0.049 CID_169703 | CID_169703 | |
| 0.105 | 0.085 | 0.108 | Interleukin 8 antagonist | 0.108 0.08 CID_169703 | CID_169703 | |
| 0.059 | 0.039 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.036 CID_169703 | CID_169703 | |
| 0.109 | 0.09 | 0.116 | Toll-Like receptor 2 antagonist | 0.116 0.082 CID_169703 | CID_169703 | |
| 0.046 | 0.028 | 0.046 | NMDA receptor subunit 3B antagonist | |||
| 0.061 | 0.044 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.044 CID_169703 | ||
| 0.023 | 0.005 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 CID_169703 | CID_169703 | |
| 0.078 | 0.061 | 0.078 | Glycine receptor antagonist | 0.078 0.061 CID_169703 | ||
| 0.129 | 0.112 | 0.129 | Interferon gamma antagonist | 0.129 0.112 CID_169703 | ||
| 0.074 | 0.057 | 0.075 | GABA B receptor agonist | 0.075 0.053 CID_169703 | CID_169703 | |
| 0.094 | 0.078 | 0.094 | Adenylate kinase inhibitor | 0.094 0.078 CID_169703 | ||
| 0.066 | 0.052 | 0.067 | MDM2 inhibitor | 0.067 0.047 CID_169703 | CID_169703 | |
| 0.033 | 0.02 | 0.033 | Estrogen-related receptor beta antagonist | |||
| 0.027 | 0.016 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 CID_169703 | ||
| 0.053 | 0.042 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 CID_169703 | CID_169703 | |
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_169703 | ||
| 0.086 | 0.076 | 0.097 | Protein kinase (CK2) inhibitor | 0.097 0.066 CID_169703 | CID_169703 | |
| 0.044 | 0.035 | 0.044 | Opioid mu receptor agonist | |||
| 0.053 | 0.045 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 CID_169703 | CID_169703 | |
| 0.053 | 0.045 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 CID_169703 | CID_169703 | |
| 0.05 | 0.042 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.188 | 0.181 | 0.199 | Transcription factor NF kappa B inhibitor | 0.199 0.17 CID_169703 | CID_169703 | |
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_169703 | ||
| 0.063 | 0.057 | 0.063 | Glutamate (mGluR6) antagonist | 0.063 0.057 CID_169703 | ||
| 0.02 | 0.015 | 0.02 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.013 | 0.008 | 0.013 | Egl nine homolog 3 inhibitor | 0.011 0.009 CID_169703 | ||
| 0.117 | 0.113 | 0.117 | Acetylcholine M1 receptor antagonist | 0.116 0.114 CID_169703 | ||
| 0.041 | 0.036 | 0.041 | Phosphorylase inhibitor | 0.039 0.038 CID_169703 | ||
| 0.06 | 0.055 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.053 CID_169703 | CID_169703 | |
| 0.086 | 0.081 | 0.086 | Carbonic anhydrase III inhibitor | 0.086 0.081 CID_169703 | ||
| 0.042 | 0.038 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.037 CID_169703 | ||
| 0.043 | 0.039 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.041 CID_169703 | ||
| 0.053 | 0.05 | 0.053 | Pregnane X receptor antagonist | 0.053 0.05 CID_169703 | ||
| 0.066 | 0.063 | 0.066 | Glycine receptor agonist | 0.066 0.063 CID_169703 | ||
| 0.037 | 0.035 | 0.037 | Oxytocin agonist | |||
| 0.031 | 0.028 | 0.031 | Purinergic P2Y2 antagonist | |||
| 0.089 | 0.087 | 0.092 | AMP-activated protein kinase stimulant | 0.092 0.082 CID_169703 | CID_169703 | |
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | 0.008 0.006 CID_169703 | ||
| 0.046 | 0.045 | 0.046 | Opioid agonist | |||
| 0.063 | 0.065 | 0.068 | Alpha 1 adrenoreceptor antagonist | 0.068 0.061 CID_169703 | CID_169703 | |
| 0.085 | 0.088 | 0.096 | Expectorant | 0.096 0.074 CID_169703 | CID_169703 | |
| 0.019 | 0.023 | 0.029 | Dopamine D1 agonist | 0.029 0.009 CID_169703 | CID_169703 | |
| 0.091 | 0.096 | 0.122 | DNA polymerase I inhibitor | 0.122 0.067 CID_169703 | CID_169703 | |
| 0.182 | 0.188 | 0.212 | Thioredoxin glutathione reductase inhibitor | 0.212 0.162 CID_169703 | CID_169703 | |
| 0.037 | 0.045 | 0.046 | Dihydroorotase inhibitor | 0.046 0.029 CID_169703 | CID_169703 | |
| 0.15 | 0.167 | 0.18 | Interleukin agonist | 0.18 0.139 CID_169703 | CID_169703 | |
| 0.067 | 0.085 | 0.076 | Alpha adrenoreceptor antagonist | 0.076 0.075 CID_169703 | CID_169703 | |
| 0.123 | 0.141 | 0.135 | DNA methyltransferase I inhibitor | 0.135 0.122 CID_169703 | CID_169703 | |
| 0.116 | 0.136 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.11 CID_169703 | CID_169703 | |
| 0.18 | 0.201 | 0.199 | Vasodilator, coronary | 0.199 0.183 CID_169703 | CID_169703 | |
| 0.098 | 0.122 | 0.107 | Interleukin 4 antagonist | 0.107 0.105 CID_169703 | CID_169703 | |
| 0.2 | 0.229 | 0.217 | Antibacterial | 0.217 0.21 CID_169703 | CID_169703 | |
| 0.045 | 0.076 | 0.072 | HIV-1 integrase (3'-Processing) inhibitor | 0.072 0.038 CID_169703 | CID_169703 | |
| 0.047 | 0.079 | 0.069 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 CID_169703 | CID_169703 | |
| 0.135 | 0.171 | 0.152 | Histone acetyltransferase inhibitor | 0.152 0.137 CID_169703 | CID_169703 | |
| 0.038 | 0.086 | 0.062 | Dopamine agonist | 0.062 0.05 CID_169703 | CID_169703 | |
| 0.033 | 0.088 | 0.053 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 CID_169703 | CID_169703 | |
| 0.065 | 0.121 | 0.083 | ATPase (Vacuolar H+) inhibitor | 0.083 0.071 CID_169703 | CID_169703 | |
| 0.05 | 0.107 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.052 CID_169703 | CID_169703 | |
| 0.015 | 0.086 | 0.032 | Catechol O-methyltransferase inhibitor | 0.032 0.023 CID_169703 | CID_169703 | |
| 0.118 | 0.202 | 0.138 | Death-associated protein kinase 2 inhibitor | 0.138 0.136 CID_169703 | CID_169703 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |